Oct 23, 2017 | Class Action Lawsuit, Defective Drugs, Defective Products, Diabetes, Drug Side Effects, Heart Attack Risk, Mass Tort, Pharmaceutical Litigation, Product Liability, Wrongful Death Cases
A motion was filed on October 11, 2017, by one of the persons suing Bristol-Myers Squibb Company and other defendants to transfer and consolidate all Onglyza® and Kombiglyze® cases into an MDL (multidistrict litigation) in the Northern District of California. The...
Sep 7, 2016 | Defective Drugs, Defective Products, Diabetes, Drug Side Effects, Heart Attack Risk, Personal Injury, Pharmaceutical Litigation
Onglyza is a popular medication prescribed to patients with type 2 diabetes. However, some serious side effects have been linked to this drug, including possible heart failure. Anyone who has taken or is taking this medication should know more about it. What Onglyza...
